Hiro-omi Kanayama
Tokushima University(JP)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Galectins and Cancer Biology
Most-Cited Works
- → A Molecular Classification of Papillary Renal Cell Carcinoma(2005)232 cited
- → Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia(2016)207 cited
- → The role of galectin-3 in cancer drug resistance(2007)142 cited
- → Galectin-3 Inhibits Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis by Activating Akt in Human Bladder Carcinoma Cells(2005)141 cited
- → Galectin-3 Regulates Mitochondrial Stability and Antiapoptotic Function in Response to Anticancer Drug in Prostate Cancer(2006)132 cited
- → Endogenous Galectin-3 Determines the Routing of CD95 Apoptotic Signaling Pathways(2004)130 cited
- → Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles(2004)107 cited
- Matrix metalloproteinases and bladder cancer.(2001)
- → Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial(2013)71 cited
- → Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer(2015)61 cited